Scarica l'app Stockscreener
17.17
1.59%
-0.278
Dopo l'orario di chiusura:
17.16
-0.012
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$17.45
Aprire:
$17.45
Volume 24 ore:
378.16K
Relative Volume:
0.81
Capitalizzazione di mercato:
$770.34M
Reddito:
$159.01M
Utile/perdita netta:
$-21.72M
Rapporto P/E:
-33.02
EPS:
-0.52
Flusso di cassa netto:
$-20.63M
1 W Prestazione:
-3.37%
1M Prestazione:
-5.34%
6M Prestazione:
+24.53%
1 anno Prestazione:
+113.32%
Intervallo 1D:
$17.05
$17.65
Intervallo di 1 settimana:
$16.79
$18.28
Portata 52W:
$5.55
$21.00
Axogen Inc Stock (AXGN) Company Profile
Nome
Axogen Inc
Settore
Industria
Telefono
(386) 462-6817
Indirizzo
13631 PROGRESS BLVD., ALACHUA, FL
Confronta AXGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
17.17 | 770.34M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
129.87 | 225.41B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.40 | 140.36B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.70B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.30B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.94 | 39.77B | 5.72B | 4.17B | 259.90M | 6.97 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-01 | Iniziato | Raymond James | Outperform |
| 2022-11-11 | Ripresa | Jefferies | Buy |
| 2022-05-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-03-02 | Reiterato | Lake Street | Buy |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Iniziato | Jefferies | Buy |
| 2017-11-21 | Reiterato | Lake Street | Buy |
| 2017-07-31 | Iniziato | Leerink Partners | Outperform |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Iniziato | ROTH Capital | Buy |
| 2016-11-22 | Aggiornamento | Lake Street | Hold → Buy |
| 2016-11-07 | Reiterato | Wedbush | Outperform |
| 2016-11-03 | Downgrade | Lake Street | Buy → Hold |
| 2016-08-04 | Reiterato | Wedbush | Outperform |
| 2014-05-14 | Iniziato | Dawson James | Buy |
| 2013-10-31 | Reiterato | Ladenburg Thalmann | Buy |
Mostra tutto
Axogen Inc Borsa (AXGN) Ultime notizie
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Canada
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com
Cantor maintains AxoGen stock target at $24, bullish on growth plan - Investing.com Australia
Cantor maintains AxoGen stock target at $24, bullish on growth plan By Investing.com - Investing.com South Africa
(AXGN) Technical Data - Stock Traders Daily
Principal Financial Group Inc. Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for AxoGen (NASDAQ:AXGN) - Defense World
Axogen director Amy McBride sells $100,100 in stock By Investing.com - Investing.com Canada
Insider Sell: Amy Wendell Sells 5,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Axogen director Amy McBride sells $100,100 in stock - Investing.com India
Analyst Expectations For Axogen's Future - Benzinga
Cantor Fitzgerald maintains AxoGen stock overweight rating By Investing.com - Investing.com Australia
AxoGen’s Strategic Growth and Market Positioning: Buy Rating Affirmed by Caitlin Cronin - TipRanks
Cantor Fitzgerald maintains AxoGen stock overweight rating - Investing.com India
Citizens JMP reiterates AxoGen stock with $26 target By Investing.com - Investing.com South Africa
Citizens JMP reiterates AxoGen stock with $26 target - Investing.com
14,285 Shares in AxoGen, Inc. (NASDAQ:AXGN) Bought by Y Intercept Hong Kong Ltd - Defense World
AxoGen’s Strategic Market Positioning and Anticipated BLA Approval Drive Buy Rating - TipRanks
AxoGen Unveils Strategic Priorities for 2025-2028 - TipRanks
AxoGen, Inc. (NASDAQ:AXGN) Shares Purchased by New York State Common Retirement Fund - Defense World
Leerink Partnrs Estimates AxoGen FY2029 Earnings - Defense World
Cantor Fitzgerald Decreases Earnings Estimates for AxoGen - Defense World
FY2025 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat
AxoGen (NASDAQ:AXGN) Posts Quarterly Earnings Results - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for AxoGen (NASDAQ:AXGN) Stock - Defense World
Investor Network: AxoGen, Inc. to Host Earnings Call - ACCESS Newswire
AxoGen Reports Strong Growth and Positive Outlook - TipRanks
Canaccord Genuity Group Raises AxoGen (NASDAQ:AXGN) Price Target to $26.00 - MarketBeat
AxoGen Q4 2024 Earnings Preview - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q4 2024 Earnings Call Transcript - Insider Monkey
The 12% return this week takes Axogen's (NASDAQ:AXGN) shareholders three-year gains to 122% - Simply Wall St
JMP lifts AxoGen stock price target to $26 from $20 By Investing.com - Investing.com South Africa
JMP lifts AxoGen stock price target to $26 from $20 - Investing.com
AxoGen price target raised to $26 from $20 at Citizens JMP - TipRanks
Axogen Q4 2024 revenue up 15.1% to USD 49.4M - Medical Buyer
Leerink raises AxoGen stock price target to $25, maintains Outperform By Investing.com - Investing.com Australia
Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Raymond James lifts AxoGen stock target to $25, maintains Outperform By Investing.com - Investing.com Australia
Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... - Yahoo Finance
Axogen, Inc. To Host Analyst & Investor Day on March 4th - GlobeNewswire
Canaccord lifts AxoGen stock price target to $26, maintains buy rating By Investing.com - Investing.com South Africa
Canaccord lifts AxoGen stock price target to $26, maintains buy rating - Investing.com India
Raymond James lifts AxoGen stock target to $25, maintains Outperform - Investing.com
Axogen Inc earnings beat by $0.04, revenue topped estimates - Investing.com Canada
AxoGen: Q4 Earnings Snapshot - mySA
AxoGen stock price target raised to $24 by Cantor Fitzgerald - Investing.com Canada
Leerink raises AxoGen stock price target to $25, maintains Outperform - Investing.com India
Axogen stock soars to 52-week high, hits $19.25 - Investing.com
Axogen Inc Azioni (AXGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Axogen Inc Azioni (AXGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wendell Amy McBride | Director |
Mar 03 '25 |
Sale |
20.02 |
5,000 |
100,100 |
97,899 |
| DeVinney Erick Wayne | Chief Innovation Officer |
Feb 28 '25 |
Option Exercise |
0.00 |
24,799 |
0 |
209,301 |
3.50%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):